NASH may soon be the leading indication for liver transplantation
Obesity-related liver disease appears to have replaced hepatitis C virus (HCV) infection as the most common cause of chronic liver disease (CLD), due to the upward obesity trends as well as the introduction of direct-acting antivirals, and current data indicate that nonalcoholic steatohepatitis (NASH) is on trajectory to become the leading indication for liver transplantation in the US.
